Alzamend Neuro Inc (ALZN) concluded trading on Thursday at a closing price of $3.19, with 0.28 million shares of worth about $0.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -71.64% during that period and on June 12, 2025 the price saw a loss of about -4.49%. Currently the company’s common shares owned by public are about 0.80M shares, out of which, 0.78M shares are available for trading.
Stock saw a price change of -14.25% in past 5 days and over the past one month there was a price change of -23.68%. Year-to-date (YTD), ALZN shares are showing a performance of -69.44% which decreased to -93.67% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.06 but also hit the highest price of $135.54 during that period. The average intraday trading volume for Alzamend Neuro Inc shares is 1.46 million. The stock is currently trading -12.02% below its 20-day simple moving average (SMA20), while that difference is down -39.93% for SMA50 and it goes to -69.60% lower than SMA200.
Alzamend Neuro Inc (NASDAQ: ALZN) currently have 0.80M outstanding shares and institutions hold larger chunk of about 0.88% of that.
The stock has a current market capitalization of $2.56M and its 3Y-monthly beta is at -0.28. It has posted earnings per share of -$27.58 in the same period. It has Quick Ratio of 5.44 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALZN, volatility over the week remained 2.54% while standing at 15.02% over the month.
Stock’s fiscal year EPS is expected to rise by 91.02% while it is estimated to decrease by -28.03% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Ascendiant Capital Markets on October 01, 2021 offering a Buy rating for the stock and assigned a target price of $8 to it.
